Horn Margaret A 4
4 · Revolution Medicines, Inc. · Filed Oct 15, 2024
Insider Transaction Report
Form 4
Horn Margaret A
Chief Operating Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2024-10-11−5,369→ 97,382 totalExercise: $4.09From: 2023-03-13Exp: 2029-03-12→ Common Stock (5,369 underlying) - Exercise/Conversion
Common Stock
2024-10-11$4.09/sh+5,369$21,959→ 182,320 total - Exercise/Conversion
Common Stock
2024-10-11$4.09/sh+44,631$182,541→ 176,951 total - Sale
Common Stock
2024-10-11$50.34/sh−50,000$2,517,055→ 132,320 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-10-11−44,631→ 0 totalExercise: $4.09From: 2023-03-13Exp: 2029-03-12→ Common Stock (44,631 underlying)
Footnotes (3)
- [F1]Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 22, 2024.
- [F2]Includes 77,300 restricted stock units.
- [F3]This transaction was executed in multiple trades in prices ranging from $50.00 to $50.82, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.